Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder.
Monoclonal antibodies conjugated with superparamagnetic iron oxide particles allow magnetic resonance imaging detection of lymphocytes in the mouse brain.
Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.
Immunomodulatory effects of Vitamin D in multiple sclerosis.
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.
Benefit of Endermology on Indurations and Panniculitis/Lipoatrophy During Relapsing-Remitting Multiple Sclerosis Long-Term Treatment with Glatiramer Acetate.
Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination.
B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis.
Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude.
Involvement of AMPK, IKβα-NFκB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model.
Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
Does interferon Beta-1a impact pure-tone hearing sensitivity among individuals with multiple sclerosis?
Epidemiology of Neuromyelitis Optica in the United States: A Multicenter AnalysisEpidemiology of NMO.
Vitamin D intake and incidence of multiple sclerosis.
Dynamic regulatory network controlling TH17 cell differentiation.
The mystery of missing heritability: Genetic interactions create phantom heritability.
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
Combination Treatment of Interferon β-1b and Warfarin for a Patient With Baló's Concentric Sclerosis and Antiphospholipid Syndrome.
Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of β-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis.
Gut microbiota composition and relapse risk in pediatric MS: A pilot study.
Copolymer 1 inhibits manifestations of graft rejection.
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.
The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation.
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study.
Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.

Pages